{"doi":"10.1056/jp200405200000009","title":"Unknown","abstract":null,"journal":null,"year":null,"id":657216,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"A Failed New Antipsychotic Drug","abstract":"Some researchers have suggested that the amelioration of psychosis and the extrapyramidal side effects associated with antipsychotic drugs occur via the blockade of dopamine D2 receptors, but other scientists have suggested that actions on other dopamine receptors may also be …","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19162232","pmcid":null,"openalex_id":"https://openalex.org/W2762952367","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.30702184,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":null,"oa_locations":[{"url":"http://www.jwatch.org/jp200405200000009/2004/05/20/failed-new-antipsychotic-drug","host_type":"journal"}],"fields_of_study":["Schizophrenia research and treatment","Mental Health and Psychiatry","Electroconvulsive Therapy Studies"],"mesh_terms":[],"keywords":["Antipsychotic","Dopamine receptor D2","Dopamine","Psychosis","Antipsychotic drug","Medicine","Dopamine hypothesis of schizophrenia","Drug","Blockade","Dopamine receptor","Pharmacology","Schizophrenia (object-oriented programming)","Dopamine receptor D3","Psychiatry","Receptor","Neuroscience","Psychology","Internal medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-12T00:15:23.590189Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}